BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 12651662)

  • 1. Nifedipine potentiates the antinociceptive effect of endomorphin-1 microinjected into the periaqueductal gray in rats.
    Cousins MJ; Hao S; Mamiya K; Takahata O; Iwasaki H; Mata M; Fink DJ
    Anesth Analg; 2003 Apr; 96(4):1065-1071. PubMed ID: 12651662
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intrathecal endomorphin-1 produces antinociceptive activities modulated by alpha 2-adrenoceptors in the rat tail flick, tail pressure and formalin tests.
    Hao S; Takahata O; Iwasaki H
    Life Sci; 2000 Mar; 66(15):PL195-204. PubMed ID: 11210721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paradoxical hyperalgesia induced by mu-opioid receptor agonist endomorphin-2, but not endomorphin-1, microinjected into the centromedial amygdala of the rat.
    Terashvili M; Wu HE; Schwasinger E; Tseng LF
    Eur J Pharmacol; 2007 Jan; 554(2-3):137-44. PubMed ID: 17112504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential responses to morphine-induced analgesia in the tail-flick test.
    Cecchi M; Capriles N; Watson SJ; Akil H
    Behav Brain Res; 2008 Dec; 194(2):146-51. PubMed ID: 18656501
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The antinociceptive effects of endomorphin-1 and endomorphin-2 in diabetic mice.
    Kamei J; Zushida K; Ohsawa M; Nagase H
    Eur J Pharmacol; 2000 Mar; 391(1-2):91-6. PubMed ID: 10720639
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential development of antinociceptive tolerance to morphine and fentanyl is not linked to efficacy in the ventrolateral periaqueductal gray of the rat.
    Bobeck EN; Haseman RA; Hong D; Ingram SL; Morgan MM
    J Pain; 2012 Aug; 13(8):799-807. PubMed ID: 22766006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Electroacupuncture potentiates the antinociceptive effect of intrathecal endomorphin-1 in the rat formalin test.
    Hao S; Takahata O; Iwasaki H
    Neurosci Lett; 2000 Jun; 287(1):9-12. PubMed ID: 10841978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential antinociception induced by spinally administered endomorphin-1 and endomorphin-2 in the mouse.
    Ohsawa M; Mizoguchi H; Narita M; Nagase H; Kampine JP; Tseng LF
    J Pharmacol Exp Ther; 2001 Aug; 298(2):592-7. PubMed ID: 11454920
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential antinociceptive effects of endomorphin-1 and endomorphin-2 in the mouse.
    Tseng LF; Narita M; Suganuma C; Mizoguchi H; Ohsawa M; Nagase H; Kampine JP
    J Pharmacol Exp Ther; 2000 Feb; 292(2):576-83. PubMed ID: 10640294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glutamate modulation of antinociception, but not tolerance, produced by morphine microinjection into the periaqueductal gray of the rat.
    Morgan MM; Bobeck EN; Ingram SL
    Brain Res; 2009 Oct; 1295():59-66. PubMed ID: 19664608
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Opioid antagonists in the periaqueductal gray inhibit morphine and beta-endorphin analgesia elicited from the amygdala of rats.
    Pavlovic ZW; Cooper ML; Bodnar RJ
    Brain Res; 1996 Nov; 741(1-2):13-26. PubMed ID: 9001699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endogenous opioids acting at a medullary mu-opioid receptor contribute to the behavioral antinociception produced by GABA antagonism in the midbrain periaqueductal gray.
    Roychowdhury SM; Fields HL
    Neuroscience; 1996 Oct; 74(3):863-72. PubMed ID: 8884782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential mechanisms of antianalgesia induced by endomorphin-1 and endomorphin-2 in the ventral periaqueductal gray of the rat.
    Terashvili M; Wu HE; Leitermann RJ; Sun HS; Clithero AD; Tseng LF
    J Pharmacol Exp Ther; 2005 Mar; 312(3):1257-65. PubMed ID: 15542622
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential involvement of mu-opioid receptor subtypes in endomorphin-1- and -2-induced antinociception.
    Sakurada S; Zadina JE; Kastin AJ; Katsuyama S; Fujimura T; Murayama K; Yuki M; Ueda H; Sakurada T
    Eur J Pharmacol; 1999 May; 372(1):25-30. PubMed ID: 10374711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antinociceptive and behavioral activation responses elicited by d-Pro(2)-endomorphin-2 in the ventrolateral periaqueductal gray are sensitive to sex and gonadectomy differences in rats.
    Krzanowska EK; Znamensky V; Wilk S; Bodnar RJ
    Peptides; 2000 May; 21(5):705-15. PubMed ID: 10876054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dynorphinergic mechanism mediating endomorphin-2-induced antianalgesia in the mouse spinal cord.
    Wu HE; Sun HS; Darpolar M; Leitermann RJ; Kampine JP; Tseng LF
    J Pharmacol Exp Ther; 2003 Dec; 307(3):1135-41. PubMed ID: 14557378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antinociception produced by microinjection of morphine in the rat periaqueductal gray is enhanced in the foot, but not the tail, by intrathecal injection of alpha1-adrenoceptor antagonists.
    Fang F; Proudfit HK
    Brain Res; 1998 Apr; 790(1-2):14-24. PubMed ID: 9593804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential antinociceptive effects induced by intrathecally administered endomorphin-1 and endomorphin-2 in the mouse.
    Sakurada S; Hayashi T; Yuhki M; Orito T; Zadina JE; Kastin AJ; Fujimura T; Murayama K; Sakurada C; Sakurada T; Narita M; Suzuki T; Tan-no K; Tseng LF
    Eur J Pharmacol; 2001 Sep; 427(3):203-10. PubMed ID: 11567650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cross-tolerance between the different mu-opioid receptor agonists endomorphin-1, endomorphin-2 and morphine at the spinal level in the rat.
    Labuz D; Przewlocki R; Przewlocka B
    Neurosci Lett; 2002 Dec; 334(2):127-30. PubMed ID: 12435488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. (+)-Morphine and (-)-morphine stereoselectively attenuate the (-)-morphine-produced tail-flick inhibition via the naloxone-sensitive sigma receptor in the ventral periaqueductal gray of the rat.
    Terashvili M; Wu HE; Moore RM; Harder DR; Tseng LF
    Eur J Pharmacol; 2007 Sep; 571(1):1-7. PubMed ID: 17597599
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.